Armando E. Giuliano
#108,690
Most Influential Person Now
Armando E. Giuliano's AcademicInfluence.com Rankings
Armando E. Giulianomedical Degrees
Medical
#1416
World Rank
#1753
Historical Rank
Surgery
#108
World Rank
#148
Historical Rank
Armando E. Giulianophilosophy Degrees
Philosophy
#4498
World Rank
#7033
Historical Rank
Logic
#1932
World Rank
#2805
Historical Rank
Download Badge
Medical Philosophy
Why Is Armando E. Giuliano Influential?
(Suggest an Edit or Addition)Armando E. Giuliano's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. (2011) (2624)
- American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. (2005) (1736)
- Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer (1994) (1398)
- Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. (2010) (1113)
- Sentinel lymphadenectomy in breast cancer. (1997) (1091)
- Improved Axillary Staging of Breast Cancer with Sentinel Lymphadenectomy (1995) (959)
- Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial (2017) (932)
- Lymphatic mapping and sentinel lymph node biopsy in early‐stage breast carcinoma (2006) (674)
- Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual (2017) (627)
- Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. (2007) (624)
- Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. (1997) (617)
- Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. (2007) (612)
- Bacteriology of necrotizing fasciitis. (1977) (570)
- Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. (2000) (548)
- Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. (2017) (543)
- Most Early Disseminated Cancer Cells Detected in Bone Marrow of Breast Cancer Patients Have a Putative Breast Cancer Stem Cell Phenotype (2006) (541)
- Surgical Complications Associated With Sentinel Lymph Node Biopsy: Results From a Prospective International Cooperative Group Trial (2006) (530)
- Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. (2014) (510)
- Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. (1987) (480)
- Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. (2014) (457)
- Proceedings of the Consensus Conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, Pennsylvania (2002) (437)
- Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? (1999) (431)
- Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. (2011) (426)
- Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. (2014) (394)
- Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial (2010) (375)
- Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. (1998) (363)
- Accumulation of Glucosylceramides in Multidrug-resistant Cancer Cells* (1996) (343)
- Prediction of breast tumor progression by integrity of free circulating DNA in serum. (2006) (327)
- Proceedings of the Consensus Conference on the Role of Sentinel Lymph Node Biopsy in Carcinoma of the Breast April 19–22, 2001, Philadelphia, PA, USA (2002) (311)
- Ceramide glycosylation potentiates cellular multidrug resistance (2001) (310)
- Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer (2014) (309)
- Radiation field design in the ACOSOG Z0011 (Alliance) Trial. (2014) (306)
- Sentinel-lymph-node biopsy for breast cancer--not yet the standard of care. (1998) (306)
- Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer (2018) (304)
- Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node (2000) (302)
- Standard for Breast Conservation Therapy in the Management of Invasive Breast Carcinoma (2002) (295)
- Agents that Reverse Multidrug Resistance, Tamoxifen, Verapamil, and Cyclosporin A, Block Glycosphingolipid Metabolism by Inhibiting Ceramide Glycosylation in Human Cancer Cells* (1997) (290)
- Expression of Glucosylceramide Synthase, Converting Ceramide to Glucosylceramide, Confers Adriamycin Resistance in Human Breast Cancer Cells* (1999) (273)
- Preoperative localization and radioguided parathyroid surgery. (2003) (247)
- Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. (1999) (229)
- Sentinel lymphadenectomy in thyroid malignant neoplasms. (1998) (211)
- Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms. (1998) (205)
- FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer. (2010) (202)
- The rationale for planned reoperation after unplanned total excision of soft-tissue sarcomas. (1985) (200)
- Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. (2003) (195)
- Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. (2011) (195)
- Glucosylceramide: a marker for multiple-drug resistant cancers. (1998) (177)
- The Prognostic Significance of Micrometastases in Breast Cancer: A SEER Population-Based Analysis (2007) (173)
- Distinct Hypermethylation Profile of Primary Breast Cancer Is Associated with Sentinel Lymph Node Metastasis (2005) (171)
- Impact of micrometastases in the sentinel node of patients with invasive breast cancer. (2009) (167)
- Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs. (2005) (163)
- Evaluation of MCF10A as a Reliable Model for Normal Human Mammary Epithelial Cells (2015) (162)
- Invasive Lobular vs. Ductal Breast Cancer: A Stage-Matched Comparison of Outcomes (2010) (160)
- Sentinel node biopsy in breast cancer. (1999) (156)
- Nipple-Sparing Mastectomy in 99 Patients With a Mean Follow-up of 5 Years (2011) (156)
- Biopsy Method and Excision Volume Do Not Affect Success Rate of Subsequent Sentinel Lymph Node Dissection in Breast Cancer (2000) (151)
- Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease. (2001) (148)
- Intraoperative examination of the sentinel lymph node for breast carcinoma staging. (1999) (146)
- The prevalence of carcinoma in palpable vs impalpable, mammographically detected lesions. (1991) (145)
- Guest editorial: Sentinel lymphadenectomy in primary breast carcinoma: An alternative to routine axillary dissection (1996) (145)
- Breast cancer lung metastasis: Molecular biology and therapeutic implications (2018) (143)
- A role for ceramide in driving cancer cell resistance to doxorubicin (2008) (141)
- Changing metastatic patterns of osteosarcoma (1984) (138)
- Taxol-induced ceramide generation and apoptosis in human breast cancer cells (2001) (138)
- Margin status and local recurrence after breast-conserving surgery. (1994) (136)
- Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy. (2004) (135)
- Role for Sentinel Lymph Node Dissection in the Management of Large (≥5 cm) Invasive Breast Cancer (2001) (135)
- Critical protein GAPDH and its regulatory mechanisms in cancer cells (2015) (133)
- Uncoupling Ceramide Glycosylation by Transfection of Glucosylceramide Synthase Antisense Reverses Adriamycin Resistance* (2000) (132)
- Sentinel Node Metastasis in Patients with Breast Carcinoma Accurately Predicts Immunohistochemically Detectable Nonsentinel Node Metastasis (1999) (127)
- Society of Surgical Oncology: Position Statement on Prophylactic Mastectomy. Approved by the Society of Surgical Oncology Executive Council, March 2007 (2007) (126)
- Thioredoxin-like 2 regulates human cancer cell growth and metastasis via redox homeostasis and NF-κB signaling. (2011) (125)
- Intradermal blue dye to identify sentinel lymph node in breast cancer (1997) (122)
- Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011. (2008) (122)
- Advances in FDG PET probes in surgical oncology. (2002) (118)
- B7–H3 Ligand Expression by Primary Breast Cancer and Associated With Regional Nodal Metastasis (2010) (117)
- Incidence and predictors of axillary metastasis in T1 carcinoma of the breast. (1996) (115)
- Sentinel Node Skills Verification and Surgeon Performance: Data From a Multicenter Clinical Trial for Early-Stage Breast Cancer (2005) (113)
- Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial. (2001) (111)
- Clinical aspects of unknown primary melanoma. (1980) (111)
- LDH and melanoma (1983) (109)
- FOXC1 Activates Smoothened-Independent Hedgehog Signaling in Basal-like Breast Cancer. (2015) (109)
- Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors (2008) (109)
- Long-Term Morbidity of Sentinel Node Biopsy Versus Complete Axillary Dissection for Unilateral Breast Cancer (2008) (108)
- Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer (2005) (105)
- Metaplastic carcinoma of the breast (1998) (103)
- Melanoma from unknown primary site and amelanotic melanoma. (1982) (103)
- Detection of Circulating Tumor Cells in Early-Stage Breast Cancer Metastasis to Axillary Lymph Nodes (2007) (101)
- Accelerated Partial Breast Irradiation After Conservative Surgery for Breast Cancer (2004) (100)
- N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing (2008) (99)
- Sentinel Lymph Node Biopsy for Local Recurrence of Breast Cancer After Breast-Conserving Therapy (2006) (99)
- ACOSOG Z0011: A randomized trial of axillary node dissection in women with clinical T1-2 N0 M0 breast cancer who have a positive sentinel node. (2010) (99)
- Manipulation of the primary breast tumor and the incidence of sentinel node metastases from invasive breast cancer. (2004) (98)
- Workshop on partial breast irradiation: state of the art and the science, Bethesda, MD, December 8-10, 2002. (2004) (96)
- Surgical Delay of the Nipple–Areolar Complex: A Powerful Technique to Maximize Nipple Viability Following Nipple-Sparing Mastectomy (2012) (96)
- FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling (2012) (96)
- Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells. (2007) (93)
- Quantification of LINE1 in Circulating DNA as a Molecular Biomarker of Breast Cancer (2008) (92)
- SDZ PSC 833, the cyclosporine A analogue and multidrug resistance modulator, activates ceramide synthesis and increases vinblastine sensitivity in drug-sensitive and drug-resistant cancer cells. (1999) (92)
- Modification of ceramide metabolism increases cancer cell sensitivity to cytotoxics. (1999) (91)
- Dietary fat reduction in postmenopausal women with primary breast cancer: Phase III Women's Intervention Nutrition Study (WINS) (2005) (91)
- Comparison of Patient Characteristics and Outcomes of Contralateral Prophylactic Mastectomy and Unilateral Total Mastectomy in Breast Cancer Patients (2012) (90)
- Molecular strategy for detecting metastatic cancers with use of multiple tumor-specific MAGE-A genes. (2001) (90)
- Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized histologic criteria and image-based training. (2008) (90)
- Factors Associated With Local-Regional Recurrence After a Negative Sentinel Node Dissection: Results of the ACOSOG Z0010 Trial (2012) (89)
- FOXC1: an emerging marker and therapeutic target for cancer (2017) (89)
- Scientific Impact Recognition Award. Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors. (2007) (89)
- The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase‐polymerase chain reaction (1995) (88)
- Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast April 19 to 22, 2001, Philadelphia, Pennsylvania. (2002) (87)
- Tamoxifen retards glycosphingolipid metabolism in human cancer cells (1996) (87)
- Personalizing breast cancer staging by the inclusion of ER, PR, and HER2. (2014) (86)
- MRI versus Ultrasonography and Mammography for Preoperative Assessment of Breast Cancer (2009) (85)
- The effects of adjuvant chemotherapy on bone density in postmenopausal women with early breast cancer. (2003) (84)
- Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug‐resistant cancer cells (1999) (84)
- Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer. (2008) (84)
- Oligonucleotides blocking glucosylceramide synthase expression selectively reverse drug resistance in cancer cells Published, JLR Papers in Press, February 16, 2004. DOI 10.1194/jlr.M300486-JLR200 (2004) (83)
- Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver. (2001) (82)
- Cryosurgical palliation of metastatic neuroendocrine tumors resistant to conventional therapy. (1997) (82)
- Lymph node metastasis from ductal carcinoma in situ with microinvasion (1999) (81)
- Lymphatic Mapping Establishes the Role of BRAF Gene Mutation in Papillary Thyroid Carcinoma (2006) (80)
- Occult metastases in the axillary lymph nodes of patients with breast cancer node negative by clinical and histologic examination and conventional histology. (1991) (80)
- Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple‐marker RT‐PCR (1998) (80)
- Selective Modulation of Paracortical Dendritic Cells and T‐Lymphocytes in Breast Cancer Sentinel Lymph Nodes (2000) (80)
- Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer. (2012) (79)
- Factors affecting sentinel node localization during preoperative breast lymphoscintigraphy. (2000) (78)
- Glycosylation of ceramide potentiates cellular resistance to tumor necrosis factor-alpha-induced apoptosis. (1999) (78)
- Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer research. (2014) (77)
- Radiofrequency ablation of early-stage invasive breast tumors: an overview. (2002) (77)
- Use of aspiration cytology and frozen section examination for management of benign and malignant thyroid nodules (1991) (76)
- Mapping a pathway for axillary staging: a personal perspective on the current status of sentinel lymph node dissection for breast cancer. (1999) (74)
- Sustained c-Jun-NH2-Kinase Activity Promotes Epithelial-Mesenchymal Transition, Invasion, and Survival of Breast Cancer Cells by Regulating Extracellular Signal-Regulated Kinase Activation (2010) (74)
- Multiple primary melanoma (1979) (72)
- Outcomes for Women With Ductal Carcinoma-in-Situ and a Positive Sentinel Node: A Multi-Institutional Audit (2007) (71)
- Pathologic Examination of Sentinel Lymph Node for Breast Carcinoma (2001) (70)
- New and Important Changes in the TNM Staging System for Breast Cancer. (2018) (70)
- Assessment of DNA methylation status in early stages of breast cancer development (2013) (69)
- Hypomethylation of LINE-1 in primary tumor has poor prognosis in young breast cancer patients: a retrospective cohort study (2012) (69)
- Breast-conserving therapy for triple-negative breast cancer. (2014) (69)
- Should ACOSOG Z0011 change practice with respect to axillary lymph node dissection for a positive sentinel lymph node biopsy in breast cancer? (2012) (68)
- A novel automated assay for the rapid identification of metastatic breast carcinoma in sentinel lymph nodes (2011) (65)
- Current status of anti-human epidermal growth factor receptor 2 therapies: predicting and overcoming herceptin resistance. (2013) (65)
- Nonsentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node: implications for completion axillary node dissection. (2005) (63)
- A Randomized Prospective Trial Using Postoperative Adjuvant Chemotherapy (Adriamycin) in High‐Grade Extremity Soft‐Tissue Sarcoma (1988) (62)
- The Management of Locally Recurrent Soft‐Tissue Sarcoma (1982) (61)
- Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: 2016 American Society of Clinical Oncology Clinical Practice Guideline Update Summary. (2017) (59)
- Clinical determinants for the management of thyroid nodules by fine-needle aspiration cytology. (1992) (59)
- Sentinel node mapping for breast cancer: progress to date and prospects for the future. (2007) (58)
- The time has come to change the algorithm for the surgical management of early breast cancer. (2002) (57)
- Glucosylceramide synthase, a factor in modulating drug resistance, is overexpressed in metastatic breast carcinoma. (2011) (56)
- Survival analyses from the Women's Intervention Nutrition Study (WINS) evaluating dietary fat reduction and breast cancer outcome (2008) (56)
- Intraoperative lymphatic mapping and sentinel lymph node dissection in breast cancer. (2000) (56)
- The multidrug resistance modulator SDZ PSC 833 is a potent activator of cellular ceramide formation (1998) (55)
- ACOSOG Z0010: A multicenter prognostic study of sentinel node (SN) and bone marrow (BM) micrometastases in women with clinical T1/T2 N0 M0 breast cancer. (2010) (55)
- Tamoxifen induces selective membrane association of protein kinase C epsilon in MCF‐7 human breast cancer cells (1998) (55)
- Clinical correlations with drug sensitivities in the clonogenic assay: a retrospective study. (1982) (55)
- Delayed diagnosis of breast cancer as a result of normal mammograms. (1983) (54)
- Stanniocalcin-1: a novel molecular blood and bone marrow marker for human breast cancer. (2003) (54)
- Metabolism of short-chain ceramide by human cancer cells--implications for therapeutic approaches. (2010) (54)
- FOXC1-Induced Non-Canonical WNT5A-MMP7 Signaling Regulates Invasiveness in Triple-Negative Breast Cancer (2017) (53)
- Dermal Versus Intraparenchymal Lymphoscintigraphy of the Breast (2001) (53)
- Practical aspects in the diagnosis and management of cystosarcoma phyllodes. (1988) (52)
- What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ? (2006) (52)
- The operative management of coexisting thyroid and parathyroid disease. (1990) (52)
- Results of Ilioinguinal Dissection for Stage II Melanoma (1982) (52)
- The role of sentinel lymph node biopsy in patients with differentiated thyroid carcinoma. (2006) (50)
- Underuse of axillary dissection for the management of sentinel node micrometastases in breast cancer. (2010) (50)
- Sentinel node localization in breast cancer. (1999) (50)
- Proteomic profiling of primary breast cancer predicts axillary lymph node metastasis. (2006) (49)
- Evaluation of axillary lymphadenectomy without axillary drainage for patients undergoing breast-conserving therapy (1998) (49)
- To Cut Is to Cure: Can We Really Apply Z11 in Practice? (2011) (48)
- Ceramide toxicity and metabolism differ in wild-type and multidrug-resistant cancer cells. (1999) (47)
- Oncological and Surgical Outcomes After Nipple-Sparing Mastectomy: Do Incisions Matter? (2016) (47)
- Preoperative Breast MRI in the Surgical Treatment of Ductal Carcinoma In Situ (2012) (47)
- Evaluation of the stage IB designation of the American Joint Committee on Cancer staging system in breast cancer. (2015) (46)
- Margins: A Status Report from the Annual Meeting of the American Society of Breast Surgeons (2014) (46)
- Radioguided surgery : a comprehensive team approach (2008) (46)
- Axillary Staging in the Neoadjuvant Setting (2010) (46)
- Tamoxifen activates cellular phopholipase C and D and elicits protein kinase C translocation (1997) (45)
- Volume-controlled vs no/short-term drainage after axillary lymph node dissection in breast cancer surgery: a meta-analysis. (2009) (44)
- See One, Do Twenty-Five, Teach One: The Implementation of Sentinel Node Dissection in Breast Cancer (1999) (43)
- The utility of estrogen receptor, progesterone receptor, and Her-2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastases. (2006) (43)
- Epigenetic Analysis of Body Fluids and Tumor Tissues (2006) (43)
- Radiation Safety Considerations for Sentinel Node Techniques (1999) (43)
- Comparison of outcomes of breast conserving therapy in multifocal and unifocal invasive breast cancer. (2012) (43)
- Basal-Like Breast Cancer Defined by FOXC1 Expression Offers Superior Prognostic Value: A Retrospective Immunohistochemical Study (2011) (42)
- Serum‐mediated immunosuppression in lung cancer (1979) (42)
- Technical note: magnetic resonance imaging-guided pre-operative breast localization using "freehand technique". (1995) (42)
- Necrotizing fasciitis of the upper extremity. (1982) (41)
- Sentinel Lymph Node Biopsy for Papillary Thyroid Cancer: 12 Years of Experience at a Single Institution (2010) (41)
- Sentinel lymph node dissection for thyroid malignancy. (2000) (41)
- Differentiation of Human Induced Pluripotent Stem Cells to Mammary-like Organoids (2017) (41)
- Vital dyes in sentinel node localization. (2000) (40)
- Conservation therapy for invasive lobular carcinoma of the breast (1992) (40)
- A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group. (2004) (39)
- Predicting Nipple–Areolar Involvement Using Preoperative Breast MRI and Primary Tumor Characteristics (2013) (39)
- Triple-Negative Breast Cancer is Not Associated with Increased Likelihood of Nodal Metastases (2014) (39)
- Detection of MAGE-A3 in breast cancer patients’ sentinel lymph nodes (2001) (38)
- Impact of Consensus Guidelines by the Society of Surgical Oncology and the American Society for Radiation Oncology on Margins for Breast-Conserving Surgery in Stages 1 and 2 Invasive Breast Cancer (2015) (38)
- FOXC1 is a Critical Mediator of EGFR Function in Human Basal-like Breast Cancer (2014) (38)
- Impact of Multifocality and Lymph Node Metastasis on the Prognosis and Management of Microinvasive Breast Cancer (2013) (37)
- Nipple-areolar preservation during breast-conserving therapy for subareolar breast carcinomas. (1996) (37)
- Oncofetal antigen: a tumor-associated fetal antigen immunogenic in man. (1979) (37)
- Sentinel lymph node mapping in breast cancer: a critical reappraisal of the internal mammary chain issue. (2014) (36)
- Lymphatic mapping and sentinel lymphadenectomy (1998) (35)
- Applicability of the ACOSOG Z0011 Criteria in Women with High-Risk Node-Positive Breast Cancer Undergoing Breast Conserving Surgery (2015) (35)
- The Feasibility of Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial (2018) (35)
- Breast‐conserving surgery and radiation after augmentation mammoplasty (1994) (35)
- The role of intraoperative lymphatic mapping and sentinel lymphadenectomy in the management of patients with breast cancer. (1999) (34)
- Prognostic Value of Basal Phenotype in HER2-overexpressing Breast Cancer (2012) (34)
- Does Sentinel Lymphadenectomy Improve Staging and Alter Therapy in Elderly Women With Breast Cancer? (2000) (34)
- Therapeutic effect of sentinel lymphadenectomy in T1 breast cancer. (1998) (33)
- Enhanced de novo ceramide generation through activation of serine palmitoyltransferase by the P-glycoprotein antagonist SDZ PSC 833 in breast cancer cells. (2002) (33)
- Microsatellite Alterations Detected in the Serum of Early Stage Breast Cancer Patients (2001) (33)
- Surgical management of breast cancer in the elderly patient. (2001) (33)
- Is splenic salvage safe in the traumatized patient? (1981) (33)
- Neoadjuvant Chemotherapy, Radiation, and Limited Surgery for High Grade Soft Tissue Sarcoma of the Extremity (1988) (33)
- Management of Papillary Lesions of the Breast: Can Larger Core Needle Biopsy Samples Identify Patients Who May Avoid Surgical Excision? (2013) (32)
- Tumor characteristics predictive of sentinel node metastases in 105 consecutive patients with invasive lobular carcinoma. (2002) (32)
- Relation between DNA ploidy and the clinical behavior of phyllodes tumors (1989) (32)
- Survey of ASCO Members on Management of Sentinel Node Micrometastases in Breast Cancer: Variation in Treatment Recommendations According to Specialty (2009) (32)
- Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients. (2003) (32)
- Breast conservation management of breast tumors 4 cm or larger. (1992) (32)
- Mammographically guided fine‐needle aspiration biopsy of nonpalpable breast lesions. Can it replace open biopsy? (1991) (31)
- Comparison of wire localization, radioactive seed, and Savi scout® radar for management of surgical breast disease (2020) (31)
- Role of conservation therapy for invasive lobular carcinoma of the breast (2006) (31)
- Sentinel lymph node biopsy in patients with early-stage breast cancer: status of the National Clinical Trials. (2003) (31)
- The Florid Subtype of Lobular Carcinoma In Situ: Marker or Precursor for Invasive Lobular Carcinoma? (2011) (31)
- Clarifying the role of fine-needle aspiration cytologic evaluation and frozen section examination in the operative management of thyroid cancer. (1989) (30)
- SDZ PSC 833 the drug resistance modulator activates cellular ceramide formation by a pathway independent of P-glycoprotein. (2000) (30)
- Aspiration biopsy smear pattern as a predictor of biologic behavior in adenocarcinoma of the breast. (1992) (30)
- Not Performing a Sentinel Node Biopsy for Older Patients With Early-Stage Invasive Breast Cancer. (2015) (30)
- Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07) (2020) (29)
- Weight of normal parathyroid glands in patients with parathyroid adenomas. (2004) (28)
- Elesclomol, counteracted by Akt survival signaling, enhances the apoptotic effect of chemotherapy drugs in breast cancer cells (2010) (28)
- Senior peer counseling by telephone for psychosocial support after breast cancer surgery: effects at six months. (2012) (28)
- FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance (2016) (28)
- Local and regional control in breast cancer: role of sentinel node biopsy. (2011) (28)
- Long-term follow-up confirms the oncologic safety of sentinel node biopsy without axillary dissection in node-negative breast cancer patients. (2010) (27)
- Patterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breast cancer. (2005) (27)
- Troubleshooting Sentinel Lymph Node Biopsy in Breast Cancer Surgery (2016) (27)
- Sentinel lymph node dissection and the current status of American trials on breast lymphatic mapping. (2004) (26)
- Characterization of primary human mammary epithelial cells isolated and propagated by conditional reprogrammed cell culture (2017) (26)
- Immunity against breast cancer by TERT DNA vaccine primed with chemokine CCL21 (2007) (25)
- Intraoperative pathologic examination of the sentinel lymph node (1998) (25)
- Role of sentinel lymph node dissection in breast cancer (2000) (24)
- Breast cancers: estrogen and progesterone receptor status as a predictor of in vitro chemotherapeutic response. (1984) (24)
- Lymphatic mapping and sentinel node biopsy in breast cancer. (1997) (23)
- Nonpalpable versus palpable invasive breast tumors treated with breast-conserving surgical management. (1996) (22)
- Contribution of SLN investigation with 99mTc-nanocolloid in clinical staging of thyroid cancer: technical feasibility (2007) (22)
- Skin‐sparing mastectomy (2003) (22)
- Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer (2017) (22)
- The antitumor phospholipid analog, hexadecylphosphocholine, activates cellular phospholipase D. (1996) (22)
- Sentinel node in the era of neoadjuvant therapy and locally advanced breast cancer. (2003) (21)
- Long-term Outcome of Patients Managed With Sentinel Lymph Node Biopsy Alone for Node-Negative Invasive Breast Cancer. (2012) (21)
- Transcriptome and proteome characterization of surface ectoderm cells differentiated from human iPSCs (2016) (21)
- Selective Sentinel Node Plus Additional Non-Sentinel Node Biopsy Based on an FDG-PET/CT Scan in Early Breast Cancer Patients: Single Institutional Experience (2009) (20)
- The use of sentinel lymphadenectomy to identify candidates for postoperative adjuvant therapy of melanoma and breast cancer. (2001) (20)
- Lymphoscintigraphy and Lymphatic Mapping for Identification of Sentinel Lymph Nodes (2001) (20)
- Sentinel Node Biopsy: Standard of Care (2003) (19)
- Gene expression comparison between primary triple‐negative breast cancer and paired axillary and sentinel lymph node metastasis (2019) (19)
- Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer (2014) (19)
- Sophisticated techniques detect obscure lymph node metastases in carcinoma of the breast (1998) (18)
- Adherence to the National Quality Forum (NQF) Breast Cancer Measures Within Cancer Clinical Trials: A Review From ACOSOG Z0010 (2010) (18)
- Guidelines for Guidelines: An Assessment of the American Society of Breast Surgeons Contralateral Prophylactic Mastectomy Consensus Statement (2016) (18)
- Immunologic aspects of unknown primary melanoma. (1980) (18)
- Colorectal carcinoma: Analysis of management in two medical eras (1993) (18)
- Factors influencing accrual to ACOSOG Z0011, a randomized phase III trial of axillary dissection vs. observation for sentinel node positive breast cancer. (2006) (16)
- Palindromic amplification of the ERBB2 oncogene in primary HER2-positive breast tumors (2017) (16)
- The Positive Appearance Center: an innovative concept in comprehensive psychosocial cancer care. (1995) (16)
- Sentinel Node Biopsy and Improved Patient Care (2015) (16)
- Current status of sentinel lymphadenectomy in breast cancer. (2001) (16)
- Patterns in the Use of Axillary Operations for Patients with Node-Positive Breast Cancer After Neoadjuvant Chemotherapy: A National Cancer Database (NCDB) Analysis (2019) (15)
- Training Senior Peer Counselors to Provide Telephone Support for Newly Diagnosed Breast Cancer Survivors (2010) (15)
- Primary tumor classification according to methylation pattern is prognostic in patients with early stage ER-negative breast cancer (2012) (15)
- Neoadjuvant Endocrine Therapy in Clinical Practice: A Review. (2021) (14)
- Desmoid tumor occurring after reconstruction mammaplasty for breast carcinoma. (1995) (14)
- Predicting nipple-areolar involvement using preoperative breast MRI and primary tumor characteristics. (2011) (14)
- Adjuvant chemo‐lmmunotherapy in stage II carcinoma of the breast (1986) (14)
- Primary Hyperparathyroidism and Delirium in The Elderly (1988) (14)
- Global Forum of Cancer Surgeons: Perspectives on Barriers to Surgical Care for Cancer Patients and Potential Solutions (2019) (14)
- Sentinel Lymph Node Mapping in Breast Cancer (2017) (14)
- Long-term clinical impact of sentinel lymph node biopsy in breast cancer and cutaneous melanoma. (2014) (13)
- Preliminary Results: Double Lumpectomies for Multicentric Breast Carcinoma (2012) (13)
- The current role of sentinel node biopsy in the treatment of breast cancer. (2004) (13)
- Postoperative treatment of patients after liver resection for trauma: a follow-up study. (1977) (13)
- Extraperitoneal Laparoscopically Assisted Ilioinguinal Lymphadenectomy for Treatment of Malignant Melanoma (1998) (13)
- Current management of ductal carcinoma in situ. (1995) (13)
- Elevated C1orf63 expression is correlated with CDK10 and predicts better outcome for advanced breast cancers: a retrospective study (2015) (13)
- Long-term management and outcome of parathyroidectomy for sporadic primary multiple-gland disease. (2001) (13)
- Impediment of Replication Forks by Long Non-coding RNA Provokes Chromosomal Rearrangements by Error-Prone Restart. (2017) (13)
- Ten-year survival results of ACOSOG Z0011: A randomized trial of axillary node dissection in women with clinical T1-2 N0 M0 breast cancer who have a positive sentinel node (Alliance). (2016) (13)
- Planned segmentectomy. A necessity for breast carcinoma. (1993) (12)
- Breast Cancer Research and Treatment 2001 Reviewers (2004) (12)
- Neoadjuvant Chemotherapy and Surgical Management of the Axilla in Breast Cancer: A Review of Current Data. (2015) (12)
- Society of Surgical OncologyeAmerican Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer (2015) (12)
- Is Axillary Lymph Node Dissection Necessary After a Positive Sentinel Lymph Node Biopsy? (2017) (12)
- The role of the sentinel lymph node in the management of patients with breast cancer. (1996) (12)
- Potential and pitfalls of sentinel node detection in breast cancer. (2000) (11)
- Recognition of an epitope of a breast cancer antigen by human antibody (1999) (11)
- Breast cancer presenting as renal colic. (1978) (11)
- Global Forum of Cancer Surgeons: Declaration of Intent (2017) (11)
- Bilateral Mastectomy as Overtreatment for Breast Cancer in Women Age Forty Years and Younger with Unilateral Operable Invasive Breast Cancer (2017) (11)
- Basal Protein Expression Is Associated With Worse Outcome and Trastuzamab Resistance in HER2+ Invasive Breast Cancer. (2015) (11)
- Sentinel lymphadenectomy in node negative breast cancer. (2000) (11)
- Molecular lymphatic mapping of the sentinel lymph node. (2002) (11)
- Outcomes in patients with small node‐negative invasive breast cancer (2019) (11)
- Modification of the Sentinel Node Technique: It Was a Hit in New York, But Will It Play in Poughkeepsie? (2001) (10)
- Management of the axilla. (2013) (10)
- Current Status of Breast Organoid Models (2021) (10)
- Reply to letter: Are the standard tangential breast irradiation fields used in the ACOSOG Z0011 trial really covering the entire axilla? (2013) (10)
- Sentinel lymph node mapping for primary breast cancer (2005) (10)
- Rheumatoid factor in melanoma patients: Alterations of humoral tumor immunity in vitro (1979) (10)
- The evolution of sentinel node biopsy for breast cancer: Personal experience (2019) (10)
- Intraoperative loss of core biopsy clips: clinical implications. (2008) (10)
- Comparison of Nodal Metastasis Between BRCA Mutation Carriers and Non-BRCA Mutation Carriers with Breast Cancer (2014) (9)
- Preoperative axillary imaging with percutaneous lymph node biopsy is valuable in the contemporary management of patients with breast cancer: Hieken TJ, Trull BC, Boughey JC, et al (Mayo Clinic, Rochester, MN) Surgery 154:831-840, 2013 § (2014) (9)
- Comparison of Multiple Wire, Radioactive Seed, and Savi Scout® Radar Localizations for Management of Surgical Breast Disease (2020) (9)
- Minimally Invasive Radioguided Parathyroidectomy in Primary Hyperparathyroidism (2008) (9)
- New and important changes in breast cancer TNM: incorporation of biologic factors into staging (2019) (9)
- T lymphocyte subsets in patients with malignant melanoma (1981) (9)
- Feasibility of breast-conserving therapy for younger women with breast cancer. (1996) (9)
- Abstract P5-14-19: Radiation field design on the ACOSOG Z0011 trial (2013) (9)
- Contemporary Guidelines in Whole-Breast Irradiation: An Alternative Perspective. (2019) (8)
- Methylene Blue Dye—A Safe and Effective Alternative for Sentinel Lymph Node Localization (2009) (8)
- Reconstruction among patients undergoing mastectomy: the effect of surgical deserts. (2018) (8)
- Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast Cancer (2021) (8)
- Recurrence patterns following a negative sentinel lymph node biopsy in patients with early-stage breast cancer. (2004) (8)
- Sentinel lymphadenectomy in breast cancer (1999) (8)
- The Anatomy and Physiology of Lymphatic Circulation (2008) (8)
- Changes in utilization of axillary dissection in women with invasive breast cancer and sentinel node metastasis after the ACOSOG Z0011 trial (2021) (8)
- Recurrent primary hyperparathyroidism due to Type 1 parathyromatosis (2017) (8)
- FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort (2016) (8)
- Flat epithelial atypia on core needle biopsy does not always mandate excisional biopsy (2020) (8)
- Resistance to receptor-blocking therapies primes tumors as targets for HER3-homing nanobiologics (2017) (7)
- A chemokine regulatory loop induces cholesterol synthesis in lung-colonizing triple-negative breast cancer cells to fuel metastatic growth (2021) (7)
- Cosmetic Outcomes Following Breast-Conservation Surgery and Radiation for Multiple Ipsilateral Breast Cancer: Data from the Alliance Z11102 Study (2020) (7)
- The staging value of sentinel lymph node biopsy for breast cancer: translating pathologic findings to clinical practice. (2016) (7)
- Why remove four by chance when one will suffice? (2001) (7)
- Global Forum of Cancer Surgeons: A Steady Voice for Cancer Surgeons to Improve Surgical Care for Cancer Patients Globally (2018) (7)
- Three decades of evolving treatment for melanoma: No improvement in survival? (2005) (7)
- Origin of metallic particles resembling microcalcifications on mammograms after use of abrasive cautery-tip cleaning pads during breast surgery: experimental demonstration. (2000) (6)
- Male Breast Cancer: 13-Year Single Institution Experience (2020) (6)
- Lumpectomy Margins for Invasive Breast Cancer and Ductal Carcinoma in Situ: Current Guideline Recommendations, Their Implications, and Impact. (2020) (6)
- Overuse of Preoperative Staging of Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer (2019) (6)
- The Hybrid Delay: A New Approach for Nipple-sparing Mastectomy in Macromastia (2020) (6)
- Nomogram-based estimate of axillary nodal involvement in ACOSOG Z0011 (Alliance): validation and association with radiation protocol variations (2020) (6)
- Use of aspiration cytology and frozen section examination for management of benign and malignant thyroid nodules (1992) (6)
- Quantitative assessment reveals the dominance of duplicated sequences in germline-derived extrachromosomal circular DNA (2021) (6)
- COMMENTARY Workshop on Partial Breast Irradiation: State of the Art and the Science, Bethesda, MD, (2004) (6)
- Serum-mediated immunosuppression in cancer. (1977) (6)
- A randomized, double-blind, placebo-controlled trial of testosterone for treatment of postmenopausal women with aromatase inhibitor-induced arthralgias: Alliance study A221102 (2020) (5)
- Positive Bone Marrow Biopsy Is Associated with a Decreased Disease-Free Survival in Patients with Operable Breast Cancer (2010) (5)
- Oncofetal antigen-I (OFA-I) relative antigenicity on melanoma cells (1981) (5)
- Inhibition of lobuloalveolar development by FOXC1 overexpression in the mouse mammary gland (2017) (5)
- Evolution of the Staging System in Breast Cancer (2017) (5)
- An Update on Prognosis in Breast Cancer Patients with Extensive Axillary Disease (2008) (5)
- The fragility of a structurally diverse duplication block triggers recurrent genomic amplification (2020) (5)
- Comparative efficacy of three lymphoscintigraphic agents (1995) (5)
- Current status of sentinel lymph node dissection in breast cancer (1999) (5)
- The first BGICC consensus and recommendations for breast cancer awareness, early detection and risk reduction in low‐ and middle‐income countries and the MENA region (2021) (5)
- Staging for breast carcinoma. (1989) (5)
- Tamoxifen elicits rapid transmembrane lipid signal responses in human breast cancer cells (2004) (5)
- Upstaging of Fibroepithelial Lesions: A Single-Institution Experience (2021) (5)
- Micrometastatic nodal disease in breast cancer—the dilemma continues (2000) (5)
- Use Pre- and Intra-Operative Data To Predict Probability of Positive Non-Sentinel Lymph Nodes. (2009) (5)
- Hypermethylation of adenosine triphosphate-binding cassette transporter genes in primary hyperparathyroidism and its effect on sestamibi imaging. (2007) (5)
- Alterations in Breast Cancer Biomarkers Following Neoadjuvant Therapy (2021) (5)
- Evidence-based surgery. Canadian Association of General Surgeons and American College of Surgeons Evidence Based Reviews in Surgery. 19. The effect of a decision aid on knowledge and treatment decision making for breast cancer. (2006) (4)
- One-stage repair of colovaginal fistula complicating acute diverticulitis. (1990) (4)
- Women Could Avoid Axillary Lymph Node Dissection by Choosing Breast-Conserving Therapy Instead of Mastectomy (2021) (4)
- Abstract P3-09-09: Pre-operative pembrolizumab (pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC) (2020) (4)
- Specificity of antibody induced in sarcoma patients immunized with allogeneic sarcoma cells. (1980) (4)
- Identification of triptonide as a therapeutic agent for triple negative breast cancer treatment (2021) (4)
- In vitro sensitivity of breast carcinoma to combination chemotherapy. (1984) (4)
- Expanding Criteria for Prognostic Stage IA in Hormone Receptor-Positive Breast Cancer. (2021) (4)
- Reply to I.A. Voutsadakis et al and A. Goyal et al. (2014) (4)
- Impact of the extent of pathologic complete response on outcomes after neoadjuvant chemotherapy (2019) (3)
- Presenilin polymorphisms in Alzheimer's disease (1997) (3)
- Preoperative and Intraoperative Lymphatic Mapping for Radioguided Sentinel Node Biopsy in Breast Cancer (2013) (3)
- The selective use of sentinel node biopsy in ductal carcinoma in situ. (2003) (3)
- Is mastectomy undertreatment for low‐risk breast cancers eligible for breast‐conserving therapy? (2015) (3)
- Applicability of the ACOSOG Z 0011 Criteria in Women with High-Risk Node-Positive Breast Cancer Undergoing Breast Conserving Surgery (2015) (3)
- Treatment at Academic Centers Increases Likelihood of Reconstruction After Mastectomy for Breast Cancer Patients. (2019) (3)
- Reply to D.E. Gyorki et al and P.J. van Diest et al (2010) (3)
- Impact of Resident and Fellow Participation on Surgical Outcomes in Breast Conserving Surgery for Invasive Breast Cancer. (2019) (3)
- Prognostic significance of micrometastasis and isolated tumor cells in the sentinel lymph node (2011) (3)
- Does breast massage push tumor cells into sentinel nodes? (2005) (3)
- Clinicopathologic Characteristics and Patient Outcomes of Phyllodes Tumors: A Single Institution Experience (2021) (3)
- Sentinel Lymph Node Biopsy: From B04 to Tumor Genomics (2016) (3)
- Menopausal Status and Outcomes of BRCA Mutation Carriers with Breast Cancer (2018) (3)
- Preoperative pembrolizumab (Pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC). (2018) (3)
- Radioguided Surgery for Breast Cancer (2016) (3)
- Surgical Management of the Axilla in Breast Cancer: Evolving but Still Necessary (2022) (2)
- Abstract P4-16-01: A randomized, double-blind, placebo-controlled trial of testosterone (T) for aromatase inhibitor-induced arthralgias (AIA) in postmenopausal women: Alliance A221102 (2019) (2)
- Adjuvant endocrine therapy is associated with improved overall survival in elderly hormone receptor-positive breast cancer patients (2020) (2)
- Abstract OT3-04-02: Neoadjuvant Her2-targeted therapy +/- immunotherapy with pembrolizumab (neoHIP): An open label randomized phase II trial (2019) (2)
- Interactions of Tamoxifen with Lipid Signal Transduction Cascades (1996) (2)
- Neoadjuvant HER2-targeted therapy +/- immunotherapy with pembrolizumab (neoHIP): An open-label randomized phase II trial. (2022) (2)
- circRNA meets gene amplification. (2018) (2)
- Role of FOXC1 in regulation of basal-like/triple-negative breast cancer. (2009) (2)
- The pathology of nonpalpable breast cancer. (1990) (2)
- Abstract P2-09-07: Preoperative pembrolizumab (Pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC) (2019) (2)
- Chapter 24 – Surgery for Breast Cancer (2005) (2)
- Local recurrence risk factors in women treated with BCT for early-stage breast cancer. (2011) (2)
- SSO approved training programs in breast cancer care (2008) (2)
- Current status of anti-her2 therapies: predicting and overcoming herceptin resistance (2014) (2)
- Molecular Assessment of Sentinel Lymph Nodes (2008) (2)
- A randomized clinical trial on sentinel lymph node dissection versus axillary dissection: a matter of technique. (2008) (2)
- Axillary vs Sentinel Lymph Node Dissection for Invasive Breast Cancer—Reply (2011) (2)
- Node biopsy vs. full lymph node dissection for breast cancer. (2010) (1)
- Guidelines for the Use of Sentinel Lymph Node Biopsy in Patients with Ductal Carcinoma In Situ (2007) (1)
- Sentinel lymphadenectomy: a new alternative for managing early breast cancer. (2002) (1)
- hiPSC-Based Tissue Organoid Regeneration (2018) (1)
- Intraoperative lymphatic mapping and sentinel lymph node dissection in breast cancer (2013) (1)
- Assessment of MINT 17 methylation in primary breast cancer and normal breast epithelia: A preliminary study (2008) (1)
- Adjacent skin rotation flap for large defect in primary breast tumor (2018) (1)
- Abstract #5532: Pathologic response to neoadjuvant chemotherapy for breast cancer: Linked to enzymes that metabolize ceramide? (2009) (1)
- Positive sentinel lymph nodes should be followed by axillary lymph node dissection (2007) (1)
- Invasive Lobular Carcinoma-Correlation Between Imaging and Final Pathology: Is MRI Better? (2022) (1)
- Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer (2017) (1)
- Gene expression comparison between primary estrogen receptor‐positive and triple‐negative breast cancer with paired axillary lymph node metastasis (2021) (1)
- Incidental Radiologic Findings in Breast Cancer Patients Who Undergo Staging prior to Neoadjuvant Chemotherapy (2019) (1)
- Is there a need for sentinel lymph node biopsy in microinvasive breast cancer (2012) (1)
- Reply to Comment on: “Women Could Avoid Axillary Lymph Node Dissection by Choosing Breast-Conserving Therapy Instead of Mastectomy” (2021) (1)
- Can Radiologic Tumor Size Following Neoadjuvant Therapy Reliably Guide Tissue Resection in Breast Conserving Surgery in Patients with Invasive Breast Cancer? (2020) (1)
- Reply to “Can Patients with Multiple Breast Cancers in the Same Breast Avoid Mastectomy by Having Multiple Lumpectomies to Achieve Equivalent Rates of Local Breast Cancer Recurrence? Response to the Preliminary Alliance 11102 Trial Report” (2018) (1)
- Operations for inflammatory bowel disease. (1977) (1)
- Lobular Carcinoma in Situ: A 15-Year Single Institution Review (2017) (1)
- Axillary vs Sentinel Lymph Node Dissection in Women With Invasive Breast Cancer-Reply. (2018) (1)
- Axillary Surgery (2019) (1)
- Regional Management of Breast Cancer (2010) (1)
- Sentinel node and breast cancer: a new paradigm? (1999) (1)
- Long term results of conservative therapy for invasive lobular carcinoma of the breast (2001) (1)
- Detection of CirculatingTumor Cells in Early-Stage Breast Cancer Metastasis toAxillary Lymph Nodes (2007) (1)
- Abstract PS12-09: Pre-operative pembrolizumab (Pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC) (2021) (1)
- Triple-negative breast cancer and likelihood of nodal metastates. (2013) (1)
- Reducing Complications and Margin Issues with Nipple-Sparing Mastectomy (2017) (1)
- Abstract PD10-01: The PEARL trial: Pre-operative pembrolizumab with radiation therapy in early stage triple negative breast cancer (2022) (1)
- The Practical Value of Prediction: A Semireliable Assistant (2006) (1)
- Management of the Axilla After Neoadjuvant Therapy: Current Data and Controversies (2014) (1)
- Changes in Utilization of Axillary Dissection in Women with Invasive Breast Cancer and Sentinel Node Metastasis after American College of Surgeons Oncology Group (ACOSOG) Z0011 Trial (2018) (1)
- Single-cell profile of tumor and immune cells in primary breast cancer, sentinel lymph node, and metastatic lymph node (2022) (1)
- Sentinel lymph node biopsy in breast cancer (2012) (1)
- Gene expression comparison between primary triple-negative breast cancer and matched axillary lymph node metastasis. (2019) (1)
- Prevalence of putative breast cancer stem cells (BCSC) in lymph node occult metastases (LNOM) of patients with node-negative (LN-) breast cancer (BC) (2008) (1)
- Effect of Androgen Therapy on Transgender Female-to-Male Mastectomies (2021) (1)
- Factious Desaturation Due to Isosulfan Dye Injection (2017) (1)
- Correction to: Nomogram-based estimate of axillary nodal involvement in ACOSOG Z0011 (Alliance): validation and association with radiation protocol variations (2020) (1)
- Abstract P6-09-06: Updating the AJCC TNM staging system a summary of changes (2017) (0)
- Lymphovascular Invasion and the Decision for Postmastectomy Radiation Therapy: A Cautionary Case Report (2019) (0)
- The regulatory role of glucosylceramide synthase on gene expression contributes to drug resistance in breast cancer cells (2004) (0)
- Lymphatic Mapping and the Significance of Sentinel Node Biopsy (0)
- Incidental radiologic findings in breast cancer patients who undergo staging prior to neo‐adjuvant chemotherapy (2021) (0)
- Abstract PD9-01: Expanding downstaging criteria in AJCC pathologic prognostic staging using OncotypeDx Recurrence Score® assay in T1-2N0 hormone-receptor positive patients enrolled in the TAILORx trial (2022) (0)
- Personal experience with studies of sentinel node biopsy for breast cancer (2019) (0)
- Abstract GS4-01: Impact of Breast Conservation Therapy on Local Recurrence in Patients with Multiple Ipsilateral Breast Cancer – Results from ACOSOG Z11102 (Alliance) (2023) (0)
- The Feasibility of Radiotherapy after Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial (2019) (0)
- Can axillary radiotherapy replace axillary dissection for early-stage breast cancer? (2005) (0)
- The molecular consequences of androgen activity in the human breast (2022) (0)
- 2019 SSO Presidential Address: Serendipity and Strategy on the Path of Progress (2019) (0)
- TOP1 inhibition induces bifurcated JNK/MYC signaling that dictates cancer cell sensitivity (2022) (0)
- Comparison of Surgical Outcomes after Breast Reconstruction in Patients Younger and Older than Age 65 Years: A NSQIP Analysis (2017) (0)
- TDP 2 modulates the expression of estrogen-responsive oncogenes (2023) (0)
- Breast cancer liver metastasis: Pathogenesis and clinical implications (2022) (0)
- Abstract OT3-25-01: Neoadjuvant HER2-targeted Therapy +/- Immunotherapy with Pembrolizumab (neoHIP): An Open Label Randomized Phase II Trial (2023) (0)
- Syngeneic monoclonal antibodies directed against a non-mulv antigen present on methylcholanthrene-induced murine fibrosarcomas. Abstr. (1983) (0)
- R.B., a single, 23-year-old Hopi woman presented with abnormal vaginal bleeding to the Indian Health Service Clinic. (1994) (0)
- Inhibition of lobuloalveolar development by FOXC1 overexpression in the mouse mammary gland (2017) (0)
- Abstract P5-01-06: Single cell profile of tumor and immune cells in primary triple-negative breast cancer and different sites in the axillary lymph nodes (2023) (0)
- The Applications of Plasma Cell-free DNA in Cancer Detection: Implications in the Management of Breast Cancer Patients. (2022) (0)
- Abstract P3-07-37: Quantitative analysis of T cell and macrophage immune markers in Her2-positive breast cancer (2016) (0)
- Cancer Cells to Anticancer Drugs P-Glycoprotein and Resensitizes Multidrug-Resistant Breast Glucosylceramide Synthase Blockade Down-Regulates (2005) (0)
- Abstract A59: Assessment of conditional reprogramming to generate 2D and 3D primary human mammary cell culture models (2018) (0)
- ASO Visual Abstract: Surgical Management of the Axilla in Breast Cancer—Evolving but Still Necessary (2022) (0)
- Issue Information ‐ TOC (2020) (0)
- Method of detection of local recurrence in patients following breast conserving surgery and its utility for surveillance. (2006) (0)
- Thyroid and Parathyroid Surgery (2014) (0)
- PDKL-9 Current Status of Sentinel Node Biopsy in the United States (2004) (0)
- Intra-Arterial Chemotherapy, Preoperative Radiotherapy, and Limb Salvage Surgery for High-Grade Soft-Tissue Sarcomas of the Extremity (1988) (0)
- Expanding criteria for prognostic stage IA disease in HR+ breast cancer. (2020) (0)
- Selective vs Nonselective Nonsteroidal Anti-inflammatory Drugs and Anastomotic Leakage After Colorectal Surgery (2017) (0)
- Abstract P1-01-06: Evaluation of the stage IB designation of the 7th edition of the AJCC staging system: Biologic factors are more important (2012) (0)
- Glucosylceramide synthase, a modulator of drug resistance is overexpressed in metastatic breast cancer (2006) (0)
- Author reply (0)
- Abstract 5443: FOXC1 is a critical mediator of EGFR function in basal-like breast cancer. (2013) (0)
- Prognostic Implication of Tumor-Infiltrating Lymphocytes in Patients With HER2-Positive Breast Cancer (2016) (0)
- Elevated C1orf63 expression is correlated with CDK10 and predicts better outcome for advanced breast cancers: a retrospective study (2015) (0)
- hiPSC-Based Tissue Organoid Regeneration hiPSC-Based Tissue Organoid Regeneration (2018) (0)
- Abstract P6-13-10: Therapeutic efficacy of HER3-targeted nanobiologics on resistant tumors (2016) (0)
- Papillary lesions of the breast: Can larger core needle biopsy samples identify patients who may avoid surgical excision? (2012) (0)
- Predictors of complete response to neoadjuvant chemotherapy in Breast Cancer: A National Cancer Database (NCDB) analysis (2020) (0)
- Does Prior Breast Augmentation Negatively Impact the Dosimetry of Brachytherapy-Delivered Accelerated Partial Breast Irradiation? (2016) (0)
- General surgery: limb salvage for soft tissue sarcoma of the extremities. (1985) (0)
- Commission on Cancer CP3R Compliance Rates for Treatment of Patients With Triple Negative and HER2+ Breast Cancer: A National Cancer Database Analysis (2021) (0)
- 185 POSTER Sphingolipids enhance experession of the multidrug resistance phenotype in human breast cancer cells (2006) (0)
- Abstract P4-07-32: Mammaprint and Blueprint are prognostic of outcome following neoadjuvant chemotherapy (2022) (0)
- Abstract P3-08-04: Withdrawn (2018) (0)
- Abstract #5541: Human breast cancer cells titrate challenge doses of ceramide into higher metabolites (2009) (0)
- Author reply (0)
- Scientific paper Tumor characteristics predictive of sentinel node metastases in 105 consecutive patients with invasive lobular carcinoma (2002) (0)
- Micrometastasis and axillary dissection in breast cancer - Reply (2010) (0)
- Surgical Management of the Axilla (2014) (0)
- Selective Axillary Dissection: A New Reality (2001) (0)
- Additional file 1: Figure S1. of Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer (2017) (0)
- Seminars in Breast Disease: Introduction (2004) (0)
- Priority Report Cancer Research FOXC 1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer (2010) (0)
- Atypical ductal hyperplasia: To core or excise, that is the question (2004) (0)
- Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance). (2023) (0)
- Sentinel Lymph Node Update (2006) (0)
- The basal phenotype as a clinically relevant indicator of trastuzumab resistance in HER2+ breast cancer. (2014) (0)
- Discussion: Revascularization of the Nipple-Areola Complex following Nipple-Sparing Mastectomy. (2023) (0)
- Identification of transcriptional changes with MammaPrint and BluePrint in early-stage breast cancer after neoadjuvant chemotherapy. (2022) (0)
- ASO Visual Abstract: Upstaging of Fibroepithelial Lesions—A Single-Institution Experience (2022) (0)
- Preoperative Identification of the Sentinel Lymph Node in Breast Cancer: Nathanson SD, Burke M, Slater R, et al (Henry Ford Health System, Detroit) Ann Surg Oncol 14:3102-3110, 2007 § (2008) (0)
- of Necrotizing Fasciitis (2003) (0)
- Chemotherapy and breast reconstruction. (2010) (0)
- Chapter 7 hiPSC-Based Tissue Organoid Regeneration (2018) (0)
- Expanding the Staging Criteria for T1-2N0 Hormone-Receptor Positive Breast Cancer Patients Enrolled in TAILORx (2022) (0)
- 302. Quantitative analysis and SVM-based classification of 18F-FDG PET data in mammary carcinoma (2018) (0)
- Overuse of Surveillance Breast Magnetic Resonance Imaging (MRI) in Detecting Locoregional Recurrence After Breast Cancer Treatment (2019) (0)
- Sentinel Node Biopsy Using Lymphazurin (2010) (0)
- LYMPHATIC MAPPING AND SENTINEL NODE BIOPSY IN BREAST CANCER. AUTHORS' REPLY (1997) (0)
- QS109. Validation of a Clinical Prediction Rule for Patients' Likelihood of Requiring Post-Mastectomy Radiation Therapy (2009) (0)
- Author Reply: Re: Axillary Staging in the Neoadjuvant Setting (2010) (0)
- Individualizing Axillary Management in Breast Cancer Treatment (2013) (0)
- Sentinel lymphadenectomy: accurate histopathologic staging of the axilla. (1998) (0)
- Effect of Age in Young Women With Stage I-III Triple-Negative Breast Cancer: A Report From the National Cancer Database (2017) (0)
- The value of surgical staging of the axilla (2022) (0)
- Abstract 3742: FOXC1 is a potential prognostic marker with functional significance in basal-like breast cancer (2010) (0)
- Single cell profile of tumor and immune cells in primary triple-negative breast cancer and different sites in the axillary lymph nodes. (2022) (0)
- Estrogen receptor positive primary breast tumors are more frequently associated with promoter hypermethylation (2007) (0)
- Abstract P5-01-24: DNA palindromes as novel genomic targets for unbiased, genome-wide, and rapid pan-cancer screening (2020) (0)
- Breast Cancer Treatment at Academic Centers Increases Likelihood of Reconstruction after Mastectomy (2018) (0)
- Polypectomy or surgery for malignant colonic polyps: Do we need to change the NCCN guidelines? (2016) (0)
- Impact of neoadjuvant HER2-directed therapy on HER2 status in breast cancer. (2017) (0)
- 4–15 Role of axillary ultrasound examination in the selection of breast cancer patients for sentinel node biopsy (2008) (0)
- Association of basal marker expression with outcome and trastuzumab resistance in HER2-positive breast cancer. (2014) (0)
- American Society of Breast Disease Policy Statement on The Use of Breast Magnetic Resonance Imaging (2008) (0)
- 3–24 A Prospective Evaluation of Positron Emission Tomography Scanning, Sentinel Lymph Node Biopsy, and Standard Axillary Dissection for Axillary Staging in Patients With Early Stage Breast Cancer (2005) (0)
- Abstract 2965: Generation of a human breast tissue mimetic organoid model (2021) (0)
- Abstract 1794: TXNL2 is a key regulator of reactive oxygen species levels and NF-κB activity in cancer cells (2010) (0)
- [Significance of serum determination of beta-HCG in patients with breast cancer]. (1988) (0)
- 3–8 Preoperative Lymphatic Mapping Does Not Predict the Number of Axillary Sentinel Lymph Nodes Identified during Surgery in Breast Cancer Patients (2007) (0)
- Locoregional Management of Breast Cancer Following Neoadjuvant Chemotherapy (2022) (0)
- Effects of paravertebral blocks versus liposomal bupivacaine on hospital utilization after mastectomy with reconstruction. (2022) (0)
- Translational Challenges and Therapeutic Opportunities in BRCA1-Related Breast Cancer (2017) (0)
- Thirty-day postoperative morbidity in patients with breast cancer following neoadjuvant chemotherapy. (2020) (0)
- Prospective O bservational S tudy o f S entinel Lymphadenectomy W ithout F urther A xillary D issection i n Patients W ith S entinel N ode-Negative B reast C ancer (2000) (0)
- SeniorPeerCounselingbyTelephoneforPsychosocial SupportAf terBreastCancerSurger y: EffectsatSixMonths (2012) (0)
- Comparison of multiple oncotype DX® from the same patient (2021) (0)
- Neoadjuvant HER2-targeted therapy with or without immunotherapy with pembrolizumab (neoHIP): An open label randomized phase II trial (2019) (0)
- A corrole nanobiologic crosses the blood-brain-barrier and recognizes triple negative breast cancer: Implications for targeting brain metastases (2016) (0)
- Abstract 1906: FOXC1 regulates cancer stem cells properties via inducing SMO-independent Gli activation and confers anti-Hedgehog drug resistance in basal-like breast cancer (2014) (0)
- The use of radioisotope combined with isosulfan blue dye is not superior to radioisotope alone for the identification of sentinel lymph nodes in patients with breast cancer (2009) (0)
- ASO Author Reflections: The Evolution of Axillary Management in Breast Cancer (2022) (0)
- Novel Prognostic Staging System for Patients With De Novo Metastatic Breast Cancer. (2023) (0)
- The clinicopathologic significance of FOXC1 in BRCA-mutant breast cancer. (2014) (0)
- Role of Sentinel Lymph Node Dissection Alone in Breast Cancer Survival (2012) (0)
- Chemotherapy and Breast Reconstruction: Comment on “Impact of Chemotherapy on Postoperative Complications After Mastectomy and Immediate Breast Reconstruction” (2010) (0)
- Use of preoperative prophylactic antibiotics following breast localization procedures: Do they reduce surgical site infections? (2020) (0)
- Abstract 3138: FOXC1 represses estrogen receptor-α expression via increasing NF-κB activity in breast cancer: A novel mechanism to explain antiestrogen resistance (2011) (0)
- The Current Role of Sentinel Lymph Node Biopsy in Breast, Melanoma, and Gastrointestinal Cancers (2008) (0)
- Nomogram-Based Estimate of Axillary Nodal Involvement in ACOSOG Z0011 (Alliance): Validation and Association with Radiation Protocol Variations and Outcomes (2018) (0)
- Sentinel node biopsy and regional recurrence following neoadjuvant chemotherapy in patients with isolated tumor cells: A rare event. (2022) (0)
- Should ACOSOG Z0011 change practice with respect to axillary lymph node dissection for a positive sentinel lymph node biopsy in breast cancer? (2012) (0)
- Breast Cancer Outcomes and Micrometastatic Disease (2008) (0)
- Contemporary Cancer Program Practice Profile Report (CP3R) Compliance Rates for Breast Cancer: A National Cancer Database Analysis (2021) (0)
- Micrometastasis. Preface. (2008) (0)
- Excretion of tumor‐associated antigen(s) in the urine of patients with colon carcinoma (1982) (0)
- ASO Visual Abstract: Expanding Staging Criteria in T1–2N0 Hormone Receptor-Positive Breast Cancer Patients Enrolled in TAILORx (2022) (0)
- Impact of Age in Women with Stage I-III Triple Negative Breast Cancer (TNBC): A National Cancer Data Base (2004-2014) Report (2020) (0)
- Biopsy of abnormal intramammary and axillary lymph nodes in patients without breast cancer (2018) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Armando E. Giuliano?
Armando E. Giuliano is affiliated with the following schools:
